Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Powder for oral suspension: 14.96 g, 15 g
Registered products in the Philippines
3 products registered with the Food and Drug Administration (FDA) Philippines list Calcium polystyrene sulphonate as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products3
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
K-polCalcium Polystyrene Sulphonate | 15 g Powder for Oral SuspensionAluminum Foil Sachet x 15 g (Box of 20's) | Rx | Acme Life Tech LLPIndia | Stangen Pharmaceuticals Philippines Inc. | DRP-16376 | Feb 24, 2030 | |
KalcytrapCalcium Polystyrene Sulphonate | 15 g Powder for Oral SuspensionAluminum Foil Sachet x 15 g (Box of 20's) | Rx | Acme Life Tech LLPIndia | Ellebasy Medicale Group IncImporter: Stangen Pharmaceuticals Philippines Inc | DRP-16376-01 | Feb 24, 2030 | |
ResincalCalcium Polystyrene Sulphonate | 14.96 g Powder for Oral SuspensionPaper/Aluminum/Polyethylene sachets x 15 g (Box of 26's) | Rx | Laboratorios Rubio S.A.Spain | Macropharma Corporation | DR-XY39274 | Feb 7, 2037 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .